What was Prenetics Global Ltd's revenue in Q1 FY2023?

Prenetics Global Ltd reported total revenue of $92.0M in Q1 FY2023.

What were Prenetics Global Ltd's margins in Q1 FY2023?

Prenetics Global Ltd had gross margin of 39.2% in Q1 FY2023.

Prenetics Global LtdPREEarnings & Financial Report

Nasdaq · Health Care · Laboratory Analytical Instruments

Prenetics (NASDAQ:PRE) is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer.

Q1 2023 Q3 2022 Q1 2022

Revenue

$92.0M

Gross Profit

$36.0M

Operating Profit

N/A

Net Profit

N/A

Gross Margin

39.2%

Operating Margin

N/A

Net Margin

N/A

YoY Growth

N/A

Prenetics Global Ltd Q1 FY2023 Financial Summary

Prenetics Global Ltd reported revenue of $92.0M for Q1 FY2023, with a net profit of N/A (N/A margin). Cost of goods sold was $56.0M.

Key Financial Metrics

Total Revenue	$92.0M
Net Profit	N/A
Gross Margin	39.2%
Operating Margin	N/A
Report Period	Q1 FY2023

Prenetics Global Ltd Quarterly Revenue & Net Profit History

Prenetics Global Ltd results over the last 3 reported quarters, including revenue, net profit and year-over-year growth.

Quarter	Revenue	Revenue YoY	Net Profit	Net Margin
Q1 FY2023	$92.0M	—	N/A	N/A
Q3 FY2022	$74.7M	—	N/A	N/A
Q1 FY2022	$57.5M	—	N/A	N/A

Income Statement

	Q1 2022	Q3 2022	Q1 2023
Revenue	$57.5M	$74.7M	$92.0M
YoY Growth	N/A	N/A	N/A

Balance Sheet

	Q1 2022	Q3 2022	Q1 2023
Assets	N/A	N/A	N/A
Liabilities	N/A	N/A	N/A
Equity	N/A	N/A	N/A

Cash Flow

No data available for this period